The HOXC10 antibody is a research tool used to detect the HOXC10 protein, a member of the homeobox (HOX) gene family. HOX genes encode transcription factors critical for embryonic development, particularly in regulating body axis patterning, cell differentiation, and organogenesis. HOXC10. located on chromosome 12. contains a conserved DNA-binding homeodomain and modulates gene expression by binding to specific regulatory sequences. Dysregulation of HOXC10 has been implicated in various cancers, including breast, gastric, and colorectal cancers, where it often promotes tumor progression, metastasis, or chemoresistance. In normal tissues, HOXC10 expression is tightly controlled and typically limited to specific developmental stages or cell types.
HOXC10 antibodies are widely used in techniques like Western blotting, immunohistochemistry (IHC), and immunofluorescence (IF) to study its expression patterns, subcellular localization, and interactions in both physiological and pathological contexts. Researchers also employ these antibodies to explore HOXC10's role in signaling pathways, such as Wnt/β-catenin or TGF-β, and its potential as a diagnostic or prognostic biomarker. Commercial HOXC10 antibodies are typically validated for specificity using knockout controls or siRNA-based silencing. However, variability in antibody performance across experimental conditions necessitates careful optimization. Current studies focus on its therapeutic targeting in cancers and its regulatory mechanisms in tissue regeneration.